Home News & Events New ICON survey highlights importance of combination therapies in future obesity treatment Read the press release ICON releases latest version of its Digital Platform Read the press release ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023 Read the press release Press releases 26 February 2024 ICON plc to Present at Upcoming Investor Conferences 21 February 2024 ICON Reports Fourth Quarter and Full Year 2023 Results 30 January 2024 ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call 24 January 2024 New ICON survey highlights importance of combination therapies in future obesity treatment 09 January 2024 ICON Issues Financial Guidance for Full Year 2024 08 January 2024 Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON 04 January 2024 ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference 18 December 2023 ICON wins industry accolades from TIME Magazine, Forbes and Financial Times in second half of 2023 07 December 2023 ICON secures upgraded credit rating from Moody’s Investors Service Events 18 March 2024 - 20 March 2024 Bio Europe Spring 21 March 2024 - 24 March 2024 CMAC 22 March 2024 Navigating the complexity of real-world healthcare data: choosing the right tools at the right time 24 March 2024 - 27 March 2024 MAPS Americas Annual Meeting 26 March 2024 Practical guidance for successful global regulatory submissions: Understanding FDA and PMDA data standards requirements 27 March 2024 - 29 March 2024 ASCPT 10 April 2024 - 12 April 2024 Intellus Worldwide 15 April 2024 - 17 April 2024 AMCP 16 April 2024 - 18 April 2024 Innovation Summit Awards ICON Press office enquiries Videos Media articles What’s happening in ICON